Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurochemistry of Sertraline and Bupropion in Depression
NCT00178828Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2002
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in major depressive disorder (MDD) comparing Sertraline with Bupropion (2 arms). Primary endpoint: Power spectral density of monoamine metabolite measures at Week 5. Started Oct 2002; status: completed.
02
Drugs
sertralinebupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00178828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178828.